Therapy Brands hires new COO
Therapy Brands has made yet another key hire, adding a new COO. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 25, 2020 Category: Biotechnology Authors: Tyler Patchen Source Type: news

Facing higher demand for flu shot than usual, some health systems run short
Both Allina Health System and HealthPartners Inc. are seeing flu vaccine shortages at some of their clinics amid a higher-than-usual demand for inoculations. HealthPartners said it has run out of Fluad Quadrivalent, its vaccine for patients 65 and older, and is waiting on another shipment from manufacturer Seqirus Inc. which is expected to arrive on Oct. 7. Allina, meanwhile, has said that it has seen shortages of vaccines at some of its clinics, thou gh it has remained stocked system-wide. It's… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 25, 2020 Category: Biotechnology Authors: Carrigan Miller Source Type: news

UHS ’ $28M real estate deal will expand hospital capacity
The Bexar County Hospital District Board of Managers has approved University Health System ’s purchase of two office buildings in University Park near Interstate 10 and De Zavala Road. The $28 million deal will give UHS 165,000 square feet of additional office space and enable the health system to address clinical capacity needs at its University Hospital campus nearby. “It’s goin g to be the new business center,” UHS President and CEO George Hernandez told me. “It’s going to be very… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 25, 2020 Category: Biotechnology Authors: W. Scott Bailey Source Type: news

Providence Health parent blames Covid-19 as it reports $1B loss
The parent company of Providence Health System, operator of the former Northeast D.C. hospital turned health campus, reported that it lost more than $1 billion during its fiscal 2020, harmed by virus shutdowns that stopped elective procedures and caused investment losses. St. Louis-based health system Ascension, a 150-hospital system reported revenue of $25.3 billion in the fiscal year ended June 30, essentially flat from fiscal 2019. But it operated with a net income of $1.2 billion in fiscal 2019. Providence… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 25, 2020 Category: Biotechnology Authors: Jacob Kirn Source Type: news

Symbiosis runs doctors ’ practices for them. Now it’s expanding — with new funding, software and space.
The medical coworking business launched in 2017 and has since gained traction in the marketplace. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 25, 2020 Category: Biotechnology Authors: Sara Gilgore Source Type: news

IN PERSON: Abby Drane is trying to build a better mental health care system in Kentucky
Abby Drane grew up with abuse and instability in her life. Now she's helping build a new mental health care system to provide stability to children and families in Kentucky. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 25, 2020 Category: Biotechnology Authors: David A. Mann Source Type: news

Entrepreneurs launch urgent care in Fuquay –Varina, eye expansion in Triangle
A pair of longtime friends have opened an urgent care in Fuquay-Varina, and they hope to add more across the region. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 25, 2020 Category: Biotechnology Authors: Caleb Harshberger Source Type: news

Form D Friday: Cancer biotech led by female CEO raises over $30M
Form D Friday is a Boston Business Journal feature highlighting regulatory filings from Boston-area companies raising capital for new projects or expanding their businesses. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 25, 2020 Category: Biotechnology Authors: Lucia Maffei Source Type: news

UNC researchers find 'vulnerability' in lung cancer; could lead to new treatments
Researchers at UNC-Chapel Hill say they've found a new "vulnerability" in a common form of lung cancer that could provide a promising target for a new treatment. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 25, 2020 Category: Biotechnology Authors: Seth Thomas Gulledge Source Type: news

AG Healey sues Mass. law firm, alleges pharmacy kickbacks
Keches Law Group allegedly received more than $90,000 in kickbacks from a pharmacy, including payments for limousine rentals and a yacht outing. The law firm disputes the claims. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 25, 2020 Category: Biotechnology Authors: Greg Ryan Source Type: news

Startups roundup: Biotech startup Immunaeon takes home Panasci
A weekly roundup of startup news in Buffalo (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 25, 2020 Category: Pharmaceuticals Authors: Dan Miner Source Type: news

Hawaii Department of Health uses $14M in CARES funds to bolster hospital staff statewide
More than 85% of the positions being funded by the $14 million are for medical-surgical nurses, critical care nurses, and telemetry nurses. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 25, 2020 Category: Biotechnology Authors: Olivia Peterkin Source Type: news

How Temple University Health System posted an $89M profit in fiscal 2020 despite Covid-19
Fueled by a strong performance at its flagship hospital, Temple University Health System posted an $88.8 million profit in fiscal 2020 despite the Covid-19 challenges in the last quarter. The North Philadelphia health system generated revenue of just under $2.3 billion in the fiscal year ending June 30. The health system's revenue and net income are both up from the previous year's figures of $2.25 billion and $24.95 million, respectively. "Fiscal year 2020 was an extraordinary y ear for Temple… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 25, 2020 Category: Biotechnology Authors: John George Source Type: news

Regional One Health and UTHSC to conduct clinical trials of Regeneron's COVID treatment
A promising potential treatment for COVID-19 will be tested in Memphis. Regional One Health and the University of Tennessee Health Science Center (UTHSC) are collaborating on a clinical trial program for Regeneron’s investigational drug candidate, REGN-COV2. “By enrolling in one of the clinical studies, individuals in our community suffering with COVID-19 symptom s or living with someone with COVID-19 will have the opportunity to gain early access to a potentially life-saving treatment or preventive… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 25, 2020 Category: Biotechnology Authors: Jason Bolton Source Type: news

UPMC takes a shot to improve mass-vaccination efforts among employees
One major priority group for a vaccine would be health care workers, who need to be safely on the job. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 25, 2020 Category: Biotechnology Authors: Paul J. Gough Source Type: news

Hetero launches pack of generic COVID-19 drug favipiravir at Rs 2,640
"The launch of 'Favivir 800/200' is aimed at enhancing patients' adherence to treatment regimen by reducing the number of pills they are required to consume per day," Hetero said. The product will be made available at all retail medical outlets and hospital pharmacies across the country and sold only on prescription, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 25, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets US health regulator nod for multiple sclerosis treatment drug
Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Dimethyl Fumarate delayed release capsules, (Tecfidera) in the strengths of 120 mg and 240 mg, Zydus Cadila, part of Cadila Healthcare group, said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 25, 2020 Category: Pharmaceuticals Source Type: news

Supply delays, rise in Covid cases lead to Remdesivir shortage
In Maharashtra, which has the highest number of Covid-19 cases in the country, the state health minister said due to batch failures of certain pharma companies, the drug was in short supply. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 25, 2020 Category: Pharmaceuticals Source Type: news

Small Business Awards 2020 Small Category Winner: BioLab Sciences
The CEO of BioLab Sciences talks about pivoting during Covid-19 and offers advice to other entrepreneurs looking to try their own startup. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Phoenix Business Journal staff Source Type: news

Operation Warp Speed officials applaud UC researchers' Covid-19 vaccine efforts
Federal representatives praised researchers at the University of Cincinnati today for their efforts in advancing a Covid-19 vaccine. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Liz Engel Source Type: news

Wisconsin bulks up Covid-19 testing money for private colleges
Wisconsin Gov. Tony Evers said $8 million will be given to private universities and colleges for Covid-19 testing to help stem “unprecedented and near exponential” growth of Covid-19 cases since August. Based on weekly averages, Wisconsin currently is counting 1,939 new cases a day, compared with 665 a month ago, said Andrea Palm, secretary designee for the Wisconsin Department of Health Services. Those increases are largely driven by infections of 18- to 24-year-olds who have case rates five… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Sean Ryan Source Type: news

Health Care of the Future 2020 (Innovation Award): HealthSaaS
HealthSaas' product is being used in the fight against Covid. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Christopher Bjorke Source Type: news

Health Care of the Future 2020: An OHSU doctor on why Covid is a 'kick in the tush'
Those who work in the field of infectious diseases were not surprised by the pandemic. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Health Care of the Future 2020: Dr. Paul Cieslak, Oregon's medical director for Communicable Diseases
Dr. Paul Cieslak keeps a close watch on immunization rates and emerging infectious diseases. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

The Petri Dish: PureTech hits Nasdaq and C-suite changes at Flagship startup
Biotech foundry/financier PureTech Health will launch on Nasdaq, a former Biogen exec walks away with $2.8M and Blueprint Medicines Corp. surpasses expectations. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Allison DeAngelis Source Type: news

These Ohio health system executives made more than $1M in 2018
At least two dozen non-CEO executives at Ohio's largest health systems were paid more than $1 million in salary and bonuses in 2018. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Carrie Ghose Source Type: news

Within3, a Cleveland-area life sciences communications company, raises $100M
The Lakewood, Ohio-based company said the financing round was led by Insight Partners, with participation from Silversmith Capital Partners. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Ben Miller Source Type: news

Meet Atlanta Business Chronicle's 2020 class of 40 Under Forty honorees
The new class was selected by a panel of past winners of the 40 Under Forty award from about 380 nominations submitted on the Atlanta Business Chronicle website. They will be celebrated at a virtual awards event on Nov. 5, 2020. The honorees, in alphabetical order by last name, are: TJ Abrams, senior vice president and chief marketing officer, EXOS Tope Awotona, CEO and founder, Calendly Kabir Barday, founder, president and CEO, OneTrust LLC Greg Benoit, CEO, QGenda LLC Lauren Bricks, chief operating… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Jessica Saunders Source Type: news

Redwood City medical device maker Pulmonx sets targets for $123M IPO
Pulmonx Corp., which makes minimally invasive medical devices for emphysema, set price targets Thursday for an IPO in which it hopes to raise up to $123 million. This is the Redwood City company's second attempt this year at going public after shelving an earlier plan to raise up to $86 million. It withdrew that filing after raising $66 million privately in May. The 202-employee company expects to list on the Nasdaq exchange as “LUNG.” It is offering 6.7 million shares for between $14 and $16… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Cromwell Schubarth Source Type: news

Delayed cancer screenings could result in later-stage diagnoses — and higher costs
A new study found diagnoses of six types of cancer were down by nearly 50% during the peak of the pandemic this spring — but lack of diagnosis does not mean lack of cancer. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Tracey Drury Source Type: news

Greystone Chiropractic to break ground on Tattersall Park facility
Greystone Chiropractic will be constructing a new facility at Tattersall Park. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Tyler Patchen Source Type: news

Leap Therapeutics Announces FDA Fast Track Designation Granted to DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer
CAMBRIDGE, Mass., Sept. 24, 2020 -- (Healthcare Sales & Marketing Network) -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that the U.S. Food and Drug Admin... Biopharmaceuticals, Oncology, FDA Leap Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 24, 2020 Category: Pharmaceuticals Source Type: news

Maryland contact tracing sheds some light on where people might be most exposed to Covid-19
Maryland released new data from its contact tracing operations Wednesday, shedding some light on the activities people participated in — from going to work to visiting casinos — that may have led to them being infected with Covid-19. Between July 10 and Sept. 19, 26% of the Maryland residents who tested positive and completed questionnaires said they went to work outside the home within 14 days of experiencing symptoms or rec eiving a positive test result. About 13% said they attended a social… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Drew Hansen Source Type: news

Telehealth use in Florida jumps during pandemic
Florida Medicaid providers have turned to remote medicine to connect with patients. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: News Service of Florida Source Type: news

UnitedHealth in talks to buy online pharmacy DivvyDose, report says
UnitedHealth is reportedly in advanced talks to buy DivvyDose, an Illinois-based online pharmacy. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Mark Reilly Source Type: news

Biotech focused on protein degradation raises $96M in 2nd fundraising this year
Monte Rosa Therapeutics has raised more than $128 million this year. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 24, 2020 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news

BIOCAD will produce the COVID-19 vaccine developed by Gamalei Institute
(BIOCAD) On September 23, 2020, the biotechnology company BIOCAD signed an agreement on the industrial production of the COVID-19 vaccine with the Research Center for Epidemiology and Microbiology of the Ministry of Health of Russia named after V. Gamaleya. BIOCAD becomes an industrial partner of the scientific center and will ensure the mass-scale production of the « Sputnik V » vaccine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 24, 2020 Category: Infectious Diseases Source Type: news

MEDICAL: Dual developments will expand health care in southern sector
As part of its Best Real Estate Deals of 2019 awards we are highlighting 58 real estate deals over 17 categories. Click here for the the winner and finalists for the Medical category. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: David Ajamy Source Type: news

ADC Therapeutics Submits Biologics License Application to the U.S. Food and Drug Administration for Loncastuximab Tesirine for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
LAUSANNE, Switzerland--(BUSINESS WIRE)-- September 24, 2020 -- ADC Therapeutics SA (NYSE: ADCT), a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of highly potent and targeted antibody... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - September 24, 2020 Category: Drugs & Pharmacology Source Type: news

Odyssey Investment Partners to acquire OP's ProPharma Group
ProPharma Group soon will have a new owner.   New York-based Odyssey Investment Partners LLC signed an agreement to acquire ProPharma from Linden Capital Partners for an undisclosed amount. The deal is slated to close in October and marks Odyssey’s second investment in the pharma services industry.   Overland Park, Kansas-based ProPharm a, which became a Linden Capital portfolio company in 2016, provides regulatory and compliance services to pharmaceutical, biotechnology and medical device companies.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Source Type: news

AdventHealth buys church, begins multimillion-dollar redevelopment
The Orlando-based nonprofit health system continues to grow its Florida footprint. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Ashley Gurbal Kritzer Source Type: news

Missouri Gov. Parson, wife test positive for Covid-19
Gov. Mike Parson and his wife, Teresa Parson, both have tested positive for Covid-19, the governor's office said Wednesday. Missouri's first lady was tested Wednesday morning "out of an abundance of caution" after displaying minor symptoms, according to a statement. The governor then also was tested and received a positive result. All official and campaign events have been canceled until further notice for the governo r, who is seeking to retain his post in November's election. Mike Parson "feels… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Diana Barr Source Type: news

Analysts offer 7 reasons why a Covid-19 vaccine could fail
In a new report, SVB Leerink analysts looked at where the market may be overeager as investors flock to vaccine stocks. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Allison DeAngelis Source Type: news

Mercy San Juan Medical Center prepares to open new $35 million NICU
Mercy San Juan Medical Center in Carmichael has wrapped up construction of a new $35 million neonatal intensive care unit, which is set to expand its space for newborn care more than tenfold. The new unit marks a substantial expansion of the hospital’s current NICU capacity, with 40 new NICU beds within 17,889 square feet of space. The unit replaces an older 26-bed, 1,200-square-foot NICU that was built in 1989. Dignity Health, which operates Mercy San Juan, has a foothold in NICU s ervices in… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Felicia Alvarez Source Type: news

Firm that serves Advanced Pain Management files for receivership, lays off 240
The company that provides services to the Advanced Pain Management chain in Wisconsin filed for receivership and will lay off 240 employees. The Greenfield-based business said in a press release that APM Wisconsin MSO LLC and “certain related entities” filed a voluntary Wisconsin Chapter 128 petition for receivership in Milwaukee County Circuit Court. The company said the receivership will allow a wind-down of operations and liquid ation of its remaining assets. APM Wisconsin MSO provides administrative… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Rich Kirchen Source Type: news

Oregon entering new phase of fire effort, governor says
Seven major fires remain active in Oregon, down from 10 last week. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Christopher Bjorke Source Type: news

Golden 100: How Orlando health company WeCare protects employees during Covid-19
"Employees are the No. 1 asset for every company." (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 24, 2020 Category: Biotechnology Authors: Jack Witthaus Source Type: news

Export boost to help pharma sector come out 'unscathed' from COVID-19 pandemic
CRISIL said, "In 2020-21, growth in exports at 11-12 per cent, as against 10 per cent last fiscal, will outpace growth in domestic formulations expected at 5-6 per cent from 10 per cent in 2019-20." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 24, 2020 Category: Pharmaceuticals Source Type: news

The world should get a COVID-19 vaccine by early 2021, says Microsoft founder Bill Gates
"I am optimistic that by early next year, of the six western constructs, probably three or four will have shown safety and efficacy, and four of those can be made at large scale and low cost, including AstraZeneca, Johnson& Johnson, Novavax and Sanofi," the co-chair of the Bill and Melinda Gates foundation told the ET Global Business Summit. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 24, 2020 Category: Pharmaceuticals Source Type: news

Centre does a U-turn, says no plans to make pharmaceutical marketing code mandatory
On September 18, when chemicals minister DV Sadananda Gowda was asked if the government had decided to make the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) mandatory, he said no. This is a u-turn from the government reply in the Lok Sabha on May 15, 2016 when it said: “...code was reviewed and it was now decided to make it statutory. Once the code is made statutory it is expected that the unethical practices could be controlled more effectively.” (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 24, 2020 Category: Pharmaceuticals Source Type: news